Clinical Trial Update: Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pharmacogenomics and therapeutic drug monitoring of venlafaxine in patients with depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Venlafaxine (Venlafaxine)

Snippet

Sponsor: Xijing Hospital | Conditions: Depression | Phase 4 | Status: UNKNOWN